Gordon E. Searles

672 total citations
28 papers, 486 citations indexed

About

Gordon E. Searles is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Gordon E. Searles has authored 28 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Dermatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Gordon E. Searles's work include Psoriasis: Treatment and Pathogenesis (11 papers), Autoimmune Bullous Skin Diseases (6 papers) and Dermatology and Skin Diseases (5 papers). Gordon E. Searles is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Autoimmune Bullous Skin Diseases (6 papers) and Dermatology and Skin Diseases (5 papers). Gordon E. Searles collaborates with scholars based in Canada, United States and Belgium. Gordon E. Searles's co-authors include J. Kraft, Teik Chye Ooi, M.E. Pratt, Kowichi Jimbow, Yves Poulin, Robert Bissonnette, Kim Papp, Dong Luo, Mieczysław Szyszkowicz and Norman Wasel and has published in prestigious journals such as The Lancet, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Gordon E. Searles

27 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon E. Searles Canada 12 236 118 101 69 62 28 486
S. Purwins Germany 12 329 1.4× 122 1.0× 242 2.4× 27 0.4× 54 0.9× 16 633
D. Guerrero France 11 110 0.5× 53 0.4× 42 0.4× 78 1.1× 70 1.1× 22 391
Nobuo Kuramoto Japan 11 64 0.3× 40 0.3× 34 0.3× 50 0.7× 24 0.4× 24 672
Isabelle M. Sanchez United States 13 245 1.0× 59 0.5× 154 1.5× 101 1.5× 25 0.4× 27 415
J. Vanderpuye-Orgle United States 8 57 0.2× 72 0.6× 121 1.2× 50 0.7× 39 0.6× 19 371
M. Lisa Abernethy United Kingdom 8 209 0.9× 27 0.2× 25 0.2× 287 4.2× 127 2.0× 11 630
Seitaro Iguchi Japan 11 91 0.4× 70 0.6× 50 0.5× 16 0.2× 28 0.5× 38 450
Ngoc J. Ho United States 12 64 0.3× 117 1.0× 14 0.1× 92 1.3× 72 1.2× 19 1.2k
R.J.B. Driessen Netherlands 21 522 2.2× 35 0.3× 760 7.5× 74 1.1× 20 0.3× 40 1.0k
Delano Pathirana Germany 9 160 0.7× 28 0.2× 142 1.4× 43 0.6× 12 0.2× 12 409

Countries citing papers authored by Gordon E. Searles

Since Specialization
Citations

This map shows the geographic impact of Gordon E. Searles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon E. Searles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon E. Searles more than expected).

Fields of papers citing papers by Gordon E. Searles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon E. Searles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon E. Searles. The network helps show where Gordon E. Searles may publish in the future.

Co-authorship network of co-authors of Gordon E. Searles

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon E. Searles. A scholar is included among the top collaborators of Gordon E. Searles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon E. Searles. Gordon E. Searles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynde, Charles, Jennifer Beecker, Jan Dutz, et al.. (2019). Treating to Target(s) With Interleukin-17 Inhibitors. Journal of Cutaneous Medicine and Surgery. 23(2_suppl). 3S–34S. 4 indexed citations
2.
Guenther, Lyn, Kirk Barber, Gordon E. Searles, et al.. (2015). Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines. Journal of Cutaneous Medicine and Surgery. 19(3). 205–215. 7 indexed citations
3.
Gulliver, Wayne, Charles Lynde, Jan Dutz, et al.. (2015). Think beyond the Skin. Journal of Cutaneous Medicine and Surgery. 19(1). 22–27. 27 indexed citations
4.
Searles, Gordon E., et al.. (2010). The Amazing Vanishing Canadian Dermatologist: Results from the 2006 Canadian Dermatology Association Member Survey. Journal of Cutaneous Medicine and Surgery. 14(2). 71–79. 21 indexed citations
5.
Landells, Ian, Gordon E. Searles, Robert Bissonnette, et al.. (2009). Efficacy Outcomes in Patients Using Alefacept in the AWARE Study. Journal of Cutaneous Medicine and Surgery. 13(6_suppl). S122–S130. 2 indexed citations
6.
Searles, Gordon E., Robert Bissonnette, Ian Landells, & Neil H. Shear. (2009). The Next Phase of Real-World Clinical Experience with Alefacept: The AWARE-2 Registry. Journal of Cutaneous Medicine and Surgery. 13(6_suppl). S148–S152. 1 indexed citations
7.
Searles, Gordon E., Ian Landells, Neil H. Shear, et al.. (2009). Update on Alefacept Safety. Journal of Cutaneous Medicine and Surgery. 13(6_suppl). S139–S147. 6 indexed citations
8.
Papp, Kim, Robert Bissonnette, Norman Wasel, et al.. (2008). Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study. The Lancet. 371(9621). 1337–1342. 61 indexed citations
9.
Orsted, Heather, et al.. (2007). Best Practice Recommendations for the Prevention, Diagnosis, and Treatment of Diabetic Foot Ulcers. Advances in Skin & Wound Care. 20(12). 655–669. 14 indexed citations
10.
Kraft, J. & Gordon E. Searles. (2007). Hidradenitis Suppurativa in 64 Female Patients: Retrospective Study Comparing Oral Antibiotics and Antiandrogen Therapy. Journal of Cutaneous Medicine and Surgery. 11(4). 125–131. 94 indexed citations
11.
Gupta, Aditya K., Richard G. Langley, Yves Poulin, et al.. (2004). Pathogenesis of Psoriasis and Current Challenges. Journal of Cutaneous Medicine and Surgery. 8(S1). 3–7. 10 indexed citations
12.
Lui, Harvey, Richard G. Langley, Yves Poulin, et al.. (2004). Incorporating Biologics into the Treatment of Psoriasis. Journal of Cutaneous Medicine and Surgery. 8(S1). 8–13. 2 indexed citations
13.
Gupta, Aditya K., Richard G. Langley, Yves Poulin, et al.. (2004). Pathogenesis of Psoriasis and Current Challenges. Journal of Cutaneous Medicine and Surgery. 8(1_suppl). 3–7. 3 indexed citations
14.
Maguiness, Sheilagh, et al.. (2004). The Canadian Dermatology Workforce Survey: Implications for the Future of Canadian Dermatology—Who will be your skin expert?. Journal of Cutaneous Medicine and Surgery. 8(3). 141–147. 22 indexed citations
15.
Maddin, W. Stuart, Ian Landells, Yves Poulin, et al.. (2000). Treatment of Acne Vulgaris and Prevention of Acne Scarring: Canadian Consensus Guidelines. Journal of Cutaneous Medicine and Surgery. 4(1_suppl). S4–2. 31 indexed citations
16.
Searles, Gordon E., Edward E. Tredget, & Andrew N. Lin. (1998). Fatal Toxic Epidermal Necrolysis Associated with Use of Terconazole Vaginal Suppository. Journal of Cutaneous Medicine and Surgery. 3(2). 85–87. 1 indexed citations
17.
18.
Searles, Gordon E., Walter T. Dixon, Panakkezhum D. Thomas, & Kowichi Jimbow. (1995). Divalent Cations Control Cell-Substrate Adhesion and Laminin Expression in Normal and Malignant Human Melanocytes in Early and Late Stages of Cellular Differentiation. Journal of Investigative Dermatology. 105(2). 301–308. 6 indexed citations
19.
Salopek, Thomas G., et al.. (1991). The Epidermal Melanin Unit in the Pathophysiology of Malignant Melanoma. American Journal of Dermatopathology. 13(2). 179–188. 28 indexed citations
20.
Searles, Gordon E., et al.. (1990). Primary oral Kaposi's sarcoma of the hard palate. Journal of the American Academy of Dermatology. 23(3). 518–519. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Purwins Breakdown of academic impact, for papers by D. Guerrero Breakdown of academic impact, for papers by Nobuo Kuramoto Breakdown of academic impact, for papers by Isabelle M. Sanchez Breakdown of academic impact, for papers by J. Vanderpuye-Orgle Breakdown of academic impact, for papers by M. Lisa Abernethy Breakdown of academic impact, for papers by Seitaro Iguchi Breakdown of academic impact, for papers by Ngoc J. Ho Breakdown of academic impact, for papers by R.J.B. Driessen Breakdown of academic impact, for papers by Delano Pathirana
Rankless by CCL
2026